FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2346324895> ?p ?o ?g. }

• W2346324895 endingPage "700" @default.
• W2346324895 startingPage "678" @default.
• W2346324895 abstract "Background Women with medical conditions associated with increased risk for thrombosis generally should not use estrogen-containing contraceptives; however, less is known about progestin-only contraceptives (POCs) and thrombosis risk. Objectives The objective was to identify evidence regarding the risk of venous thromboembolism (VTE) or arterial thromboembolism [stroke or acute myocardial infarction (AMI)] among women using POCs. Methods We searched the PubMed database for all articles published from database inception through January 2016 for studies examining thrombosis among women using POCs. We included studies which examined women with medical conditions associated with thrombosis risk, as well as studies of women in the general population (either without these conditions or who were not specified to have these conditions). Hormonal contraceptives of interest included progestin-only pills (POPs), injectables, implants and levonorgestrel-releasing intrauterine devices (LNG-IUDs). Outcomes of interest included VTE, stroke and AMI. Results There were 26 articles of good to poor quality that met inclusion criteria; 9 studies examined women with medical conditions and 20 examined women in the general population. Two studies found that, among smokers and women with certain thrombogenic mutations, use of depot medroxyprogesterone acetate (DMPA) had elevated odds of VTE compared with nonsmokers or those without mutations, although confidence intervals were wide and overlapped with odds among nonusers. One study found that, among women with previous VTE, use of POCs (including DMPA) was associated with a nonsignificant increased odds of recurrent VTE (all of which were among DMPA users); two other studies that examined POCs other than DMPA did not observe an association with recurrent VTE. Two studies found that use of DMPA among healthy women was also associated with increased odds of VTE. Two studies found that use of POCs for therapeutic indications was associated with increased odds of VTE. Studies did not find increased odds of VTE with POPs for contraceptive purposes, implants or LNG-IUDs nor were there increased odds of stroke or AMI with any POCs. Conclusion The majority of evidence identified by this systematic review did not suggest an increase in odds for venous or arterial events with use of most POCs. Limited evidence suggested increased odds of VTE with use of injectables (three studies) and use of POCs for therapeutic indications (two studies, one with POCs unspecified and the other with POPs). Any increase in risk likely translates to a small increase in absolute numbers of thrombotic events at the population level." @default.
• W2346324895 created "2016-06-24" @default.
• W2346324895 creator A5000602209 @default.
• W2346324895 creator A5023232025 @default.
• W2346324895 creator A5032686830 @default.
• W2346324895 creator A5059297756 @default.
• W2346324895 creator A5061734275 @default.
• W2346324895 date "2016-12-01" @default.
• W2346324895 modified "2023-10-06" @default.
• W2346324895 title "Progestin-only contraception and thromboembolism: A systematic review" @default.
• W2346324895 cites W1515400320 @default.
• W2346324895 cites W1529565841 @default.
• W2346324895 cites W1545179064 @default.
• W2346324895 cites W1548764206 @default.
• W2346324895 cites W1979306178 @default.
• W2346324895 cites W1987459939 @default.
• W2346324895 cites W1987891589 @default.
• W2346324895 cites W1999011481 @default.
• W2346324895 cites W2004956152 @default.
• W2346324895 cites W2006666326 @default.
• W2346324895 cites W2016509956 @default.
• W2346324895 cites W2017744150 @default.
• W2346324895 cites W2019008728 @default.
• W2346324895 cites W2019851346 @default.
• W2346324895 cites W2023153884 @default.
• W2346324895 cites W2023804167 @default.
• W2346324895 cites W2025449263 @default.
• W2346324895 cites W2027062965 @default.
• W2346324895 cites W2032238979 @default.
• W2346324895 cites W2036003181 @default.
• W2346324895 cites W2036762985 @default.
• W2346324895 cites W2042432382 @default.
• W2346324895 cites W2050360907 @default.
• W2346324895 cites W2052123395 @default.
• W2346324895 cites W2055073334 @default.
• W2346324895 cites W2060294108 @default.
• W2346324895 cites W2069590883 @default.
• W2346324895 cites W2074538974 @default.
• W2346324895 cites W2079412820 @default.
• W2346324895 cites W2080879494 @default.
• W2346324895 cites W2086594833 @default.
• W2346324895 cites W2106180482 @default.
• W2346324895 cites W2108404032 @default.
• W2346324895 cites W2120697964 @default.
• W2346324895 cites W2122953592 @default.
• W2346324895 cites W2126542118 @default.
• W2346324895 cites W2133917486 @default.
• W2346324895 cites W2137955943 @default.
• W2346324895 cites W2146576387 @default.
• W2346324895 cites W2147556011 @default.
• W2346324895 cites W2152774270 @default.
• W2346324895 cites W2153137569 @default.
• W2346324895 cites W2153677157 @default.
• W2346324895 cites W2156098321 @default.
• W2346324895 cites W2167745220 @default.
• W2346324895 cites W2169143572 @default.
• W2346324895 cites W2208166135 @default.
• W2346324895 cites W2334450173 @default.
• W2346324895 cites W24214998 @default.
• W2346324895 cites W2991792334 @default.
• W2346324895 cites W4233187059 @default.
• W2346324895 cites W4239671858 @default.
• W2346324895 doi "https://doi.org/10.1016/j.contraception.2016.04.014" @default.
• W2346324895 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27153743" @default.
• W2346324895 hasPublicationYear "2016" @default.
• W2346324895 type Work @default.
• W2346324895 sameAs 2346324895 @default.
• W2346324895 citedByCount "143" @default.
• W2346324895 countsByYear W23463248952016 @default.
• W2346324895 countsByYear W23463248952017 @default.
• W2346324895 countsByYear W23463248952018 @default.
• W2346324895 countsByYear W23463248952019 @default.
• W2346324895 countsByYear W23463248952020 @default.
• W2346324895 countsByYear W23463248952021 @default.
• W2346324895 countsByYear W23463248952022 @default.
• W2346324895 countsByYear W23463248952023 @default.
• W2346324895 crossrefType "journal-article" @default.
• W2346324895 hasAuthorship W2346324895A5000602209 @default.
• W2346324895 hasAuthorship W2346324895A5023232025 @default.
• W2346324895 hasAuthorship W2346324895A5032686830 @default.
• W2346324895 hasAuthorship W2346324895A5059297756 @default.
• W2346324895 hasAuthorship W2346324895A5061734275 @default.
• W2346324895 hasConcept C126322002 @default.
• W2346324895 hasConcept C127413603 @default.
• W2346324895 hasConcept C131872663 @default.
• W2346324895 hasConcept C156957248 @default.
• W2346324895 hasConcept C2776306185 @default.
• W2346324895 hasConcept C2776607906 @default.
• W2346324895 hasConcept C2777164284 @default.
• W2346324895 hasConcept C2777185221 @default.
• W2346324895 hasConcept C2779076696 @default.
• W2346324895 hasConcept C2780186607 @default.
• W2346324895 hasConcept C2780645631 @default.
• W2346324895 hasConcept C2780868729 @default.
• W2346324895 hasConcept C2908647359 @default.
• W2346324895 hasConcept C29456083 @default.
• W2346324895 hasConcept C2986817661 @default.
• W2346324895 hasConcept C71924100 @default.

• next